Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

RxMx

We’re a healthcare company with exceptional technology solutions and longstanding industry experience. Founded by doctors, we’ve built our business on the idea that by automating certain tasks, we can empower HCPs to safely administer specialty medicines without increasing their burden, so they can focus on patients who need their care.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

- PMLiVE

Nmblr

From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

View Profile

IT solutions

Company Details

RxMx
800 Third Avenue, Suite 2800, New York, New York, 10022, United States
(844) 311 3080
Contact RxMx
Website

 Latest Content from PMHub 

Beyond the patient journey: Designing for behaviour change

White Papers and Resources | March 1, 2016 | Blue Latitude Health

In 2016, it’s time to update our model for the customer journey. Customer Experience Consultant Anna Tamasi talks us through the future of journey mapping.

Should We Care About Rare Diseases? By Alastair Kent

White Papers and Resources | February 29, 2016 | Say Communications

Alastair Kent, OBE, the Director of Genetic Alliance UK and chair of Rare Disease UK tells us why it’s so important to care about rare disease and why we should...

Breaking Down the Barriers to Behaviour Change by Patrick Ladbury

White Papers and Resources | February 24, 2016 | Say Communications

Patrick Ladbury, the Director at the NSMC delves further into the barriers to behaviour change, and offers us tricks of the trade in his second instalment.

Affiliate friendly content: e-detailing materials that local markets love

White Papers and Resources | February 23, 2016 | Anthill Agency

What’s the point of marketing content that doesn’t get used?

Brand teams: They’re not what you think they are

White Papers and Resources | February 19, 2016 | Blue Latitude Health

Head of Commercial Matt Bolton of Blue Latitude Health breaks down what we mean when we talk about eliminating the last silos in pharma marketing.

Blue Latitude Health to sponsor and co-present in the Innovation Track at ProcureCon Healthcare 2016

Press Releases | February 19, 2016 | Blue Latitude Health

Blue Latitude Health’s Managing Director, Martin Brass, and Johnson & Johnson’s Director, David McKimm, to co-present on the topic “Optimising Your Marketing Spend in New Ways to Create Value for...

Why are doctors frustrated with the digitalisation of healthcare?

White Papers and Resources | February 17, 2016 | Blue Latitude Health

In this article, Customer Experience Consultant Anna Tamasi from Blue Latitude Health highlights the most common usability and user experience implications that the digitalisation of healthcare poses on doctors professional...

Changing faces – overcoming the taboo of marketing to a mature audience

White Papers and Resources | February 15, 2016 | Say Communications

Our new blog highlights the challenges for communicating to consumers who are 50+ and how they must be tackled in order to create marketing opportunities.

It’s time to get with the real world

Press Releases | February 11, 2016 | Lucid Group Communications Limited

Lucid CEO discusses the increasing importance placed on real-world data to demonstrate value

Free Thinking: From promise to practice: immuno-oncology in action

White Papers and Resources | February 9, 2016 | Inizio

Our latest Free Thinking white paper series explores what the global outlook is like for new immunotherapy products and asks key opinion leaders and payers how they’re faring both clinically...